61 – 70 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
- Contribution to journal › Letter
-
Mark
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
- Contribution to journal › Article
- 2018
-
Mark
Common measure of quality of life for people with systemic sclerosis across seven European countries : A cross-sectional study
- Contribution to journal › Article
-
Mark
Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort
- Contribution to journal › Article
-
Mark
Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis : A magnetic resonance study
- Contribution to journal › Article
-
Mark
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
- Contribution to journal › Article
-
Mark
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
- Contribution to journal › Article
- 2017
-
Mark
Update of EULAR recommendations for the treatment of systemic sclerosis
- Contribution to journal › Article
-
Mark
Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
- Contribution to journal › Article
-
Mark
Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus
- Contribution to journal › Article
